Neuromodulation Techniques in the Treatment of Chronic Tinnitus With Hearing Loss

NCT ID: NCT01944501

Last Updated: 2013-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-03-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed at trying transcranial magnetic stimulation and transcranial direct current stimulation as potential treatments to decrease tinnitus in patients with significant hearing loss.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Tinnitus is a very common condition and affects approximately 15% of the population, disrupting sleep, emotional balance and social life of the patients. Acoustic deprivation causes hearing loss and is responsible for a cascade of processes that result in the reorganization of the cortex through a synchronization of neuronal activity related to a cortical re-mapping. Consistent with the hypothesis that tinnitus is caused by abnormal activation of the auditory cortex, repetitive transcranial magnetic stimulation (rTMS) can temporarily reduce cortical hyperactivity through direct neuromodulation of the temporal cortex. Furthermore, studies have shown that transcranial direct current stimulation (tDCS) can also suppress tinnitus. Objective: To determine the effectiveness of rTMS and TDCS in the treatment of patients with chronic tinnitus and auditory loss. Methods: We performed an analytical experimental double-blind study using rTMS and tDCS in patients with chronic tinnitus and hearing loss.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tinnitus Hearing Loss

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

tinnitus hearing loss Transcranial magnetic stimulation Transcranial direct current stimulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transcranial Magnetic Stimulation

Patients receiving real transcranial magnetic stimulation

Group Type ACTIVE_COMPARATOR

Transcranial Magnetic Stimulation

Intervention Type PROCEDURE

TMS over the left temporoparietal cortex

Sham TMS

Patients receiving sham transcranial magnetic stimulation

Group Type PLACEBO_COMPARATOR

Transcranial Magnetic Stimulation

Intervention Type PROCEDURE

TMS over the left temporoparietal cortex

Transcranial Direct Current Stimulation

Patients receiving real transcranial direct current stimulation

Group Type ACTIVE_COMPARATOR

Transcranial Direct Current Stimulation

Intervention Type PROCEDURE

TDCS over the left temporoparietal cortex

Sham TDCS

Patients receiving sham transcranial direct current stimulation

Group Type PLACEBO_COMPARATOR

Transcranial Direct Current Stimulation

Intervention Type PROCEDURE

TDCS over the left temporoparietal cortex

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcranial Magnetic Stimulation

TMS over the left temporoparietal cortex

Intervention Type PROCEDURE

Transcranial Direct Current Stimulation

TDCS over the left temporoparietal cortex

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* chronic tinnitus
* hearing loss

Exclusion Criteria

* neurological diseases
* use of drugs affecting the central nervous system
* evidence of dementia
* clinical diagnosis of depression
Minimum Eligible Age

45 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Brasilia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Joaquim Brasil-Neto

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joaquim P Brasil-Neto, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Brasilia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidade de Brasília

Brasília, Federal District, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CFSNCC2013

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CFSNCC2013

Identifier Type: -

Identifier Source: org_study_id